Stevanato Group S.p.A.

NYSE:STVN

Medical - Instruments & Supplies

Healthcare
$15.36 +3.90%

+$0.67 today

Market cap
$4.20B
Beta
0.78
P/E (TTM)
29.9
EPS (TTM)
$0.52
Dividend yield
0.35%
52W Low $12.89High $28.00

Volume 0.61M

Average 0.52M

STVN Total Current Liabilities

All obligations due within one year.

Stevanato Group S.p.A.NYSE: STVN

Total Current Liabilities · Q2 FY2026 · quarter ended Jun 2026

Total current liabilities rises 20.1% from a year ago

Total current liabilities stood at €578.26M at the end of Q2 FY2026, up 20.1% from a year earlier and up 3.2% from the prior quarter. Over 3 fiscal years it compounded at +5.0% a year.

Context

  • Total current liabilities amounted to 22.1% of total assets at the end of Q2 FY2026, up 1.6 pp from a year earlier.
  • Total current liabilities increased in 2 of the last 3 fiscal years.

What to watch

Whether total current liabilities keeps rising in the next quarterly balance sheet after a +20.1% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
€578.26M+3.2% QoQ
Last fiscal yearDec 2025
€535.57M+12.2% YoY
Year agoJun 2025
€481.61M+20.1% since
Total Current Liabilities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+20.1%——
1 year+12.2%——
3-year CAGR+5.0%——
5-year CAGR——
10-year CAGR——

Total Current Liabilities history

EUR · from the balance sheet

Latest · FY2025
535.57M EUR
Year-over-year change
+12.2%
4-year CAGR
+12.1%

Total Current Liabilities vs competitors

How STVN compares with its peers on the latest reported figures

  • Peers report in different currencies, so total current liabilities is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of +20.1% is the 3rd highest of 11, against a peer median of +5.4%.
  • Total current liabilities amounts to 22.1% of total assets for STVN, versus a peer median of 19.8%.
STVN Competitors
Total Current Liabilities for STVN and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
BLCOBausch + Lomb CorporationJun 2026$1.89B USD+2.7%+14.0%13.6%
BTSGBrightSpring Health Services, Inc. Common StockSep 2026$1.71B USD+10.4%+25.6%27.3%
AVTRAvantor, Inc.Jun 2026$1.38B USD-46.3%-6.0%11.9%
ATRAptarGroup, Inc.Jun 2026$1.14B USD-17.0%+8.3%22.1%
TFXTeleflex IncorporatedJun 2026$720.38M USD+0.6%+9.4%10.6%
STVNStevanato Group S.p.A.Jun 2026€578.26M EUR+20.1%+5.0%22.1%
AXSMAxsome Therapeutics, Inc.Jun 2026$460.45M USD+34.6%+57.7%60.5%
MASIMasimo CorporationApr 2026$325.4M USD-40.5%-16.1%19.8%
CHEChemed CorporationJun 2026$319.85M USD+21.2%-1.1%20.2%
MMSIMerit Medical Systems, Inc.Sep 2026$265.08M USD+15.0%+2.8%—
NUVLNuvalent, Inc.Mar 2026$81.05M USD+8.0%+67.3%6.1%
Peer median (excluding STVN) —+5.4%+8.9%19.8%

Competitors are the stored peer set for STVN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

EUR
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents411.04M228.74M69.6M98.27M130.54M
Short-term Investments27.17M27.91M749K02.2M
Net Receivables278.42M369.48M522.48M529.87M542.17M
Inventory148.92M213.25M255.32M245.22M268.09M
Other Current Assets49K5.69M3.63M933K(8.6M)
Total Current Assets865.97M845.78M861.89M880.12M934.4M
Property, Plant & Equipment (Net)415.41M660.69M1.05B1.26B1.4B
Goodwill47.24M47.24M49.98M49.98M49.96M
Intangible Assets31.93M32.16M30.99M33.59M36.85M
Long-term Investments1.97M1.83M5.15M5.64M6M
Tax Assets55.88M69.21M76.25M95.34M103.86M
Other Non-current Assets447K2.8M577K08.6M
Total Non-current Assets552.87M813.92M1.21B1.45B1.61B
Total Assets1.42B1.66B2.07B2.33B2.54B
Account Payables164.79M239.18M277.82M231.02M263.19M
Short-term Debt37.17M64.63M135.6M106.84M121.69M
Tax Payables27.82M42.09M30.82M32.06M0
Deferred Revenue50.61M53.89M58.8M44.67M43.78M
Other Current Liabilities5.33M(3.73M)11.15M15.45M106.91M
Total Current Liabilities338.62M462.5M574.39M477.47M535.57M
Long-term Debt183.99M133.75M242.05M305.23M337.64M
Deferred Tax Liabilities19.11M20.95M9.62M12.56M13.29M
Deferred Revenue (Non-current)0039.42M44.05M98.76M
Other Non-current Liabilities17.9M31.93M60.35M73.32M62.07M
Total Non-current Liabilities238.56M201.29M364.54M446.96M521.38M
Total Liabilities577.18M663.79M938.93M924.43M1.06B
Common Stock21.7M21.7M21.7M22.23M22.22M
Retained Earnings0623.35M757.86M863.44M876.41M
Accumulated OCI686.06M(10.49M)(9.11M)(13.75M)54.95M
Other Stockholders Equity134.32M0000
Minority Interest(415K)(220K)115K46K37.98K
Total Equity841.66M995.91M1.13B1.4B1.49B
Total Debt244.29M218.37M396.59M428.97M470.7M
Net Debt(166.75M)(10.37M)326.99M330.7M340.16M

Stevanato Group S.p.A.

NYSE:STVN

Intrinsic Alpha fair value

Locked

Current Price

$15.36

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.